Deutsche Bank Aktiengesellschaft Raises HCA Healthcare (NYSE:HCA) Price Target to $375.00

HCA Healthcare (NYSE:HCA) had its price objective lifted by Deutsche Bank Aktiengesellschaft from $359.00 to $375.00 in a report published on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities analysts have also recently issued reports about the stock. Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an equal weight rating in a research note on Thursday, March 28th. TD Cowen dropped their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a buy rating on the stock in a research note on Tuesday, April 30th. Baird R W raised shares of HCA Healthcare to a strong-buy rating in a research note on Thursday, May 30th. Oppenheimer boosted their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an outperform rating in a research report on Monday, April 29th. Finally, Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $322.00 to $329.00 and gave the stock an outperform rating in a research report on Monday, April 29th. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and a consensus price target of $326.53.

HCA Healthcare Stock Down 1.9 %

Shares of HCA opened at $315.12 on Friday. The company’s 50-day simple moving average is $325.96 and its 200-day simple moving average is $317.82. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. HCA Healthcare has a 1 year low of $215.96 and a 1 year high of $344.20. The stock has a market capitalization of $82.53 billion, a PE ratio of 15.71, a P/E/G ratio of 1.49 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter last year, the company earned $4.93 earnings per share. The firm’s revenue for the quarter was up 11.2% on a year-over-year basis. Analysts forecast that HCA Healthcare will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.84%. The ex-dividend date of this dividend was Friday, June 14th. HCA Healthcare’s payout ratio is presently 13.16%.

Insider Activity

In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of the stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Jeffrey E. Cohen sold 1,650 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the transaction, the senior vice president now directly owns 5,185 shares in the company, valued at approximately $1,622,905. The disclosure for this sale can be found here. Insiders have sold 12,397 shares of company stock valued at $3,921,929 over the last 90 days. 1.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Trexquant Investment LP bought a new position in HCA Healthcare in the third quarter valued at approximately $1,825,000. Tower Research Capital LLC TRC grew its stake in HCA Healthcare by 71.4% in the third quarter. Tower Research Capital LLC TRC now owns 6,029 shares of the company’s stock valued at $1,483,000 after purchasing an additional 2,511 shares in the last quarter. Gotham Asset Management LLC grew its stake in HCA Healthcare by 2.4% in the third quarter. Gotham Asset Management LLC now owns 24,328 shares of the company’s stock valued at $5,984,000 after purchasing an additional 565 shares in the last quarter. Schonfeld Strategic Advisors LLC grew its stake in HCA Healthcare by 1,481.1% in the third quarter. Schonfeld Strategic Advisors LLC now owns 65,315 shares of the company’s stock valued at $16,066,000 after purchasing an additional 61,184 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec lifted its position in shares of HCA Healthcare by 3.4% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 35,152 shares of the company’s stock valued at $8,647,000 after buying an additional 1,152 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.